Heidelberg, Germany

Simon Dörsam


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovative Approaches in Ocular Drug Delivery by Simon Dörsam

Introduction

Simon Dörsam, an inventive mind located in Heidelberg, Germany, has made significant contributions to the field of ocular drug delivery. His dedication to improving medical treatments for the human eye is highlighted through his pioneering research, which aims to optimize drug delivery parameters for better therapeutic outcomes.

Latest Patents

Dörsam holds a patent for a revolutionary method titled "Test and Optimization of Medical Treatments for the Human Eye." This computer-implemented method focuses on a comprehensive approach to testing ocular drug delivery characterized by various delivery parameters. These parameters include drug type, drug concentration, drug amount, injection position, and penetration depth. The patented method involves creating a model of the human eye, defining its geometry, and setting a target drug state, ultimately simulating the ocular drug delivery to achieve optimal results.

Career Highlights

Simon Dörsam is associated with Universitäts Heidelberg, where he conducts his innovative research. His work not only demonstrates his expertise but also highlights the strong emphasis on improving treatment methodologies in ophthalmology. With his singular patent, Dörsam represents a commitment to advancing medical technology in eye care.

Collaborations

He has collaborated with notable colleagues including Elfriede Friedmann and Vladislav Olkhovskiy. Their joint efforts in the field demonstrate a synergistic approach to research, fostering an environment for innovative solutions in medical treatments.

Conclusion

Simon Dörsam’s ongoing pursuit of excellence in ocular drug delivery marks him as a vital contributor to the medical research community. His patent serves as a foundation for future advancements, ensuring that patients receive improved and effective treatments for eye-related conditions. Through his work at Universitäts Heidelberg, Dörsam continues to pave the way for innovative strategies in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…